An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Karuna Therapeutics to Host Virtual Event Highlighting Clinical Program for Psychosis in Alzheimer’s Disease
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Karuna Therapeutics (NASDAQ: KRTX) has announced a virtual event on May 25, 2022, at 8:00 a.m. ET. The hour-long webcast will focus on the progress of its clinical programs, particularly the upcoming Phase 3 study of KarXT for treating psychosis in Alzheimer’s disease. Presentations will be made by Karuna's leadership team. Interested participants can register here.
Positive
None.
Negative
None.
Webcast scheduled for Wednesday, May 25, 2022, at 8:00 a.m. ET
BOSTON--(BUSINESS WIRE)--
Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced that it will host a virtual event on Wednesday, May 25, 2022, at 8:00 a.m. ET. The one-hour webcast event will highlight progress across the ongoing and planned clinical programs of KarXT, with a primary focus on the planned Phase 3 program evaluating KarXT for the treatment of psychosis in Alzheimer’s disease.
The event will feature presentations from members of Karuna’s leadership team. To register for the event, please click here.
The webcast of the event will be available on the Investor Relations page of Karuna’s website at investors.karunatx.com.
About Karuna Therapeutics
Karuna Therapeutics is a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions. At Karuna, we understand there is a need for differentiated and more effective treatments that can help patients navigate the challenges presented by these severe and disabling disorders. Utilizing our extensive knowledge of neuroscience, we are harnessing the untapped potential of the brain in pursuit of novel pathways to develop medicines that make meaningful differences in peoples’ lives. For more information, please visit www.karunatx.com.
What is the date and time of the Karuna Therapeutics virtual event?
The Karuna Therapeutics virtual event is scheduled for May 25, 2022, at 8:00 a.m. ET.
What will be discussed during the Karuna Therapeutics webcast?
The webcast will highlight progress in Karuna's clinical programs, focusing on the Phase 3 study of KarXT for treating psychosis in Alzheimer’s disease.
How can I register for the Karuna Therapeutics event?
Registration for the Karuna Therapeutics event can be completed by clicking here.
Where can I watch the Karuna Therapeutics webcast?
The webcast will be available on the Investor Relations page of Karuna's website.
